Nurix Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
NRIX on Nasdaq
Location
1700 Owens Street, Suite 205, San Francisco, CA

Insiders trading volume in the past year

Nurix Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Third Rock Ventures III, L.P. 10%+ Owner $35.1M May 6, 2021
Column Group L P 10%+ Owner $14.4M May 7, 2021
Gwenn Hansen Chief Scientific Officer $2.14M -$197K -8.41% Oct 30, 2024
Hans van Houte Chief Financial Officer $1.73M -$1.32M -43.2% Nov 1, 2024
Christine Ring Chief Legal Officer $1.55M -$1.57M -50.3% Dec 2, 2024
Pierre Beaurang Chief Business Officer $1.21M Aug 10, 2021
Stefani Wolff EVP and COO $146K Apr 30, 2023
Lori Anne Kunkel Director $0 Jul 17, 2024
Julia P. Gregory Director May 20, 2024
Clay B. Siegall Director May 5, 2022
Jeffrey K. Tong Director, 10%+ Owner May 6, 2021
Anil Kapur Director Oct 15, 2024
Judith A. Reinsdorf Director May 20, 2024
Paul M. Silva Director May 20, 2024
David L. Lacey Director May 20, 2024
Leon Chen Director May 6, 2021
Edward C. Saltzman Director May 20, 2024
Arthur T. Sands President, CEO, Director Feb 13, 2024

Recent Insider Transactions by Companies or Individuals for Nurix Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.